DE60223262D1 - Verwendung von fucanen in der behandlung von adhäsion, arthritis und psoriasis - Google Patents

Verwendung von fucanen in der behandlung von adhäsion, arthritis und psoriasis

Info

Publication number
DE60223262D1
DE60223262D1 DE60223262T DE60223262T DE60223262D1 DE 60223262 D1 DE60223262 D1 DE 60223262D1 DE 60223262 T DE60223262 T DE 60223262T DE 60223262 T DE60223262 T DE 60223262T DE 60223262 D1 DE60223262 D1 DE 60223262D1
Authority
DE
Germany
Prior art keywords
psoriasis
arthritis
fucanes
adhesion
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60223262T
Other languages
English (en)
Other versions
DE60223262T2 (de
Inventor
John K Jackson
Helen M Burt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of British Columbia
Original Assignee
University of British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of British Columbia filed Critical University of British Columbia
Application granted granted Critical
Publication of DE60223262D1 publication Critical patent/DE60223262D1/de
Publication of DE60223262T2 publication Critical patent/DE60223262T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60223262T 2001-08-29 2002-08-29 Verwendung von fucanen in der behandlung von adhäsion, arthritis und psoriasis Expired - Lifetime DE60223262T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31536201P 2001-08-29 2001-08-29
US315362P 2001-08-29
PCT/CA2002/001337 WO2003018033A1 (en) 2001-08-29 2002-08-29 Use of fucans in the treatment of adhesions, arthritis and psoriasis

Publications (2)

Publication Number Publication Date
DE60223262D1 true DE60223262D1 (de) 2007-12-13
DE60223262T2 DE60223262T2 (de) 2008-08-14

Family

ID=23224048

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60223262T Expired - Lifetime DE60223262T2 (de) 2001-08-29 2002-08-29 Verwendung von fucanen in der behandlung von adhäsion, arthritis und psoriasis

Country Status (16)

Country Link
US (3) US6812220B2 (de)
EP (1) EP1420801B1 (de)
JP (2) JP4758063B2 (de)
KR (2) KR100910246B1 (de)
CN (2) CN101028283A (de)
AT (1) ATE376835T1 (de)
AU (1) AU2002325113B2 (de)
CA (1) CA2458853C (de)
DE (1) DE60223262T2 (de)
DK (1) DK1420801T3 (de)
ES (1) ES2295386T3 (de)
HK (1) HK1066482A1 (de)
MX (1) MXPA04001876A (de)
NZ (2) NZ532015A (de)
PT (1) PT1420801E (de)
WO (1) WO2003018033A1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632456B1 (en) * 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
US7595378B2 (en) 2001-06-13 2009-09-29 Genmab A/S Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
EP1539157B1 (de) 2002-09-18 2013-08-21 Trustees Of The University Of Pennsylvania Rapamycin zur Verwendung in der Hemmung oder Vorbeugung der choroidalen Neovaskularisation
US6982298B2 (en) 2003-01-10 2006-01-03 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US8137688B2 (en) 2003-01-10 2012-03-20 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US8138265B2 (en) 2003-01-10 2012-03-20 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US7465766B2 (en) 2004-01-08 2008-12-16 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
JP4768440B2 (ja) * 2003-03-06 2011-09-07 セルミド リミテッド 開腹手術後の癒着の予防剤
AU2004243513A1 (en) * 2003-05-30 2004-12-09 Arc Pharmaceuticals, Inc. Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
JPWO2005089800A1 (ja) * 2004-03-17 2008-01-31 株式会社ロコモジェン ｈｓＨＲＤ３を含む医薬組成物
EP1773943B1 (de) * 2004-07-09 2016-03-09 The Cleveland Clinic Foundation Mit hydroxyphenyl quervernetztes makromolekulares netzwerk und anwendungen davon
ES2729826T3 (es) * 2004-09-23 2019-11-06 Arc Medical Devices Inc Composiciones farmacéuticas y métodos relacionados para inhibir adherencias fibrosas o enfermedad inflamatoria usando fucanos con bajo contenido de sulfato
US8663639B2 (en) 2005-02-09 2014-03-04 Santen Pharmaceutical Co., Ltd. Formulations for treating ocular diseases and conditions
KR101387456B1 (ko) 2005-02-09 2014-04-21 산텐 세이야꾸 가부시키가이샤 질환 또는 상태의 치료를 위한 액체 제제
MX2007009944A (es) * 2005-02-16 2007-10-10 Md Bioalpha Co Ltd Composicion farmaceutica para el tratamiento o prevencion de enfermedades que implican obesidad, diabetes, sindrome metabolico, enfermedades neurodegenerativas y enfermedades por disfuncion mitocondrial.
US20060210697A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Infant formula composition
US20060210515A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Hair growth formula
US20060210688A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Dehydrated sports drink powder
US7749545B2 (en) * 2005-03-18 2010-07-06 Sakura Properties, Llc Fucoidan compositions and methods for dietary and nutritional supplements
US20070020358A1 (en) * 2005-03-18 2007-01-25 Mower Thomas E Sports drink concentrate
US7666448B2 (en) * 2005-03-18 2010-02-23 Sakura Properties, Llc Skin cleansing article
US20060210692A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Baby food composition
US7776365B2 (en) * 2005-03-18 2010-08-17 Sakura Properties, Llc Article with skin protecting and moisturizing compound
US20060210496A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Compositions for skin protection from ultraviolet damage
US20060210514A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Skin protection and moisturizing compositions and method of making the same
CA2851079A1 (en) 2005-04-15 2006-10-26 Albert Einstein College Of Medicine Of Yeshiva University Vitamin k for prevention and treatment of skin rash secondary to anti-egfr therapy
US20070003669A1 (en) * 2005-06-02 2007-01-04 Troy Kearl Fucoidan delivery system
US8426381B2 (en) * 2005-09-09 2013-04-23 Lucas Meyer Cosmetics Canada Inc. Polysaccharides compositions comprising fucans and galactans and their use to reduce extravasation and inflammation
EP2001438A2 (de) 2006-02-09 2008-12-17 Macusight, Inc. Stabile formulierungen sowie verfahren zu ihrer herstellung und verwendung
FR2897538B1 (fr) 2006-02-23 2008-05-02 Univ Paris Descartes Utilisation de fucanes a des fins de greffe, d'ingenierie et de regeneration osseuses
DK2001466T3 (en) 2006-03-23 2016-02-29 Santen Pharmaceutical Co Ltd LOW-DOSAGE RAPAMYCINE FOR TREATMENT OF VASCULAR PERMEABILITY-RELATED DISEASES
JP4814677B2 (ja) * 2006-03-31 2011-11-16 株式会社荏原製作所 基板保持装置および研磨装置
WO2008003317A1 (en) 2006-07-03 2008-01-10 Genmab A/S Prevention of rash in patients undergoing anti-egfr therapy
EP2249891B1 (de) 2008-02-13 2016-05-25 The Cleveland Clinic Foundation Molekulare verstärkung von extrazellulärer matrix und anwendungsverfahren
US8815953B2 (en) 2008-03-13 2014-08-26 Spectrum Pharmaceuticals, Inc. Formulations of vitamin K analogs for topical use
US8410180B2 (en) 2008-04-30 2013-04-02 The Cleveland Clinic Foundation Methods to treat urinary incontinence
JP5819189B2 (ja) 2009-03-25 2015-11-18 国立大学法人鳥取大学 軟骨生成促進剤および軟骨損傷由来疾病の予防治療剤
JO3676B1 (ar) 2009-07-27 2020-08-27 Arc Medical Devices Inc مركبات صيدلانية تضم فوكانات معدلة وطرق تتعلق بها
KR101528265B1 (ko) * 2010-04-16 2015-06-11 코웨이 주식회사 베타-라파콘을 유효성분으로 포함하는 주름개선용 화장료 조성물
AU2012284048B2 (en) * 2011-07-19 2017-03-02 Takeda Pharmaceutical Company Limited Resorption enhancers as additives to improve the oral formulation of non-anticoagulant sulfated polysaccharides
CN107580497A (zh) * 2015-02-16 2018-01-12 克桑蒂亚尔 用于预防或治疗皮肤病症的组合物
WO2017190148A1 (en) * 2016-04-29 2017-11-02 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for the prevention and treatment of surgical adhesions
US11628183B2 (en) * 2018-07-27 2023-04-18 ARC Medical Ine. Highly purified fucans for the treatment of fibrous adhesions
CN111617030B (zh) * 2020-05-22 2021-09-07 广东药科大学 壳寡糖口服液及其在制备减肥药物中的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971848A (en) * 1970-12-21 1976-07-27 Kimitsu Chemical Laboratory Co. Ltd. Lubricating composition for mucosa or epidermis
EP0293826A3 (de) 1987-06-02 1989-05-10 Stichting REGA V.Z.W. Therapeutische und prophylaktische Gabe von sulfatierten Polysacchariden gegen AIDS
JPS6431707A (en) 1987-07-28 1989-02-02 Nikko Chemicals Dermal agent for external use
JPH0714850B2 (ja) 1987-09-29 1995-02-22 喜郎 板谷 化粧料
JPH01313433A (ja) 1988-06-13 1989-12-18 Nippon Koutai Kenkyusho:Kk 抗ｈｉｖ剤
JP2853165B2 (ja) * 1989-05-29 1999-02-03 味の素株式会社 体組織癒着防止膜
FR2648463B1 (fr) * 1989-06-14 1993-01-22 Inst Fs Rech Expl Mer Polysaccharides sulfates, agent anticoagulant et agent anticomplementaire obtenus a partir de fucanes d'algues brunes et leur procede d'obtention
US6096722A (en) * 1990-08-14 2000-08-01 Isis Pharmaceuticals Inc. Antisense modulation of cell adhesion molecule expression and treatment of cell adhesion molecule-associated diseases
US5318890A (en) * 1991-05-06 1994-06-07 The Regents Of The University Of California Assays for inhibitors of leukocyte adhesion
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
JP3403496B2 (ja) 1993-09-24 2003-05-06 株式会社ヤクルト本社 抗潰瘍剤およびヘリコバクター・ピロリの定着阻害剤
JP3545789B2 (ja) * 1993-09-30 2004-07-21 味の素ファルマ株式会社 腹腔内癒着防止剤
FR2772618B1 (fr) * 1997-12-18 2000-02-18 Ifremer Utilisation de fucane comme regulateur de la reconstruction des tissus conjonctifs
EP1117835A4 (de) * 1998-10-02 2005-03-09 Genzyme Corp Adhäsionsprävention
JP4267106B2 (ja) * 1998-10-15 2009-05-27 株式会社クラレ 癒着防止用材料
JP2001052309A (ja) 1999-08-06 2001-02-23 Alps Electric Co Ltd 薄膜磁気ヘッドおよびその製造方法
SE0001631D0 (sv) * 2000-05-04 2000-05-04 Sahltech Ab New use

Also Published As

Publication number Publication date
HK1066482A1 (en) 2005-03-24
DK1420801T3 (da) 2008-03-03
NZ547609A (en) 2008-07-31
AU2002325113B2 (en) 2006-10-26
NZ532015A (en) 2006-12-22
ATE376835T1 (de) 2007-11-15
US20050074496A1 (en) 2005-04-07
KR20090019926A (ko) 2009-02-25
CN101028283A (zh) 2007-09-05
MXPA04001876A (es) 2004-06-15
CN1547478A (zh) 2004-11-17
PT1420801E (pt) 2008-01-17
WO2003018033A1 (en) 2003-03-06
US6812220B2 (en) 2004-11-02
CN1319540C (zh) 2007-06-06
KR100910246B1 (ko) 2009-07-31
JP4758063B2 (ja) 2011-08-24
US20030064958A1 (en) 2003-04-03
ES2295386T3 (es) 2008-04-16
EP1420801B1 (de) 2007-10-31
US7163930B2 (en) 2007-01-16
CA2458853A1 (en) 2003-03-06
JP2005508893A (ja) 2005-04-07
KR20040032992A (ko) 2004-04-17
DE60223262T2 (de) 2008-08-14
CA2458853C (en) 2010-10-19
US20050119216A1 (en) 2005-06-02
JP2009280597A (ja) 2009-12-03
EP1420801A1 (de) 2004-05-26

Similar Documents

Publication Publication Date Title
ATE376835T1 (de) Verwendung von fucanen in der behandlung von adhäsion, arthritis und psoriasis
ATE414089T1 (de) Verwendung von rapamycin und dessen derivaten zur behandlung von knochenverlust
ATE512163T1 (de) Verabreichung von mitteln zur behandlung von entzündungen
DE60327999D1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
MXPA05005223A (es) Diaminotriazoles utiles como inhibidores de proteinas cinasas.
BRPI0518228B8 (pt) inibidores de cinesina mitótica e uso dos mesmos
NO20061736L (no) Krystallform av epotilon B
TW200510416A (en) P38 inhibitors and methods of use thereof
DE60135732D1 (de) Topoisomerasehemmern zur behandlung von chirurgischen verklebungen
NO20055741L (no) Nye kjemiske forbindelser
DE602004010708D1 (de) Imidazopyridinsubstituierte tropanderivate mit ccr5-rezeptorantagonistischer wirkung zur behandlung von hiv und entzündungen
TW200505904A (en) Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
NO20055563L (no) Midler for behandlingen av lavere abdominale lidelser
TW200509949A (en) Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
DE602004017871D1 (de) Zubereitungen zur behandlung von arthritischen erscheinungen
BR0117009A (pt) Composiçoes para utilização no tratamento de distúrbios associados a ige
SE0302304D0 (sv) Novel compounds
GEP20053590B (en) Phenyl Heterocyclyl Ether Derivatives as Serotonin Re-Uptake Inhibitors
DE60206289D1 (de) Verwendung von bibn4096 in kombination mit anderen migränemitteln zur behandlung von migräne
ATE361071T1 (de) Verwendung von irbesartan zur vorbeugung oder behandlung pulmonaler hypertonie
ATE338566T1 (de) Aldosteronantagonist und cyclooxygenase-2 hemmer- kombinationstherapie zur verhinderung oder behandlung von entzündungsverwandten kardiovaskulären krankheiten
ATE375152T1 (de) Behandlung von gastrointestinalen erkrankungen mit n-2,3,3-tetramethylbicyclo[2.2.1]heptan-2- amine
ATE445408T1 (de) Verwendung von prolactin in der prophylaktischen krebstherapie
MXPA05007715A (es) Derivados de carboxamida y uso de los mismos como inhibidores del factor xa.
ATE302009T1 (de) Ubichinon qn zur behandlung von migräneschmerzen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition